Limits...
The clinical manifestations and treatment of male breast cancer: a report of three cases

View Article: PubMed Central

ABSTRACT

Male breast cancer is an extremely rare malignancy. We treated three male breast cancer patients. All three patients showed clinical N0 and received sentinel lymph node biopsy. Because the sentinel lymph node was positive for metastasis in one patient, a total mastectomy with axillary lymph node dissection was performed. The other two patients were negative for sentinel lymph node metastasis, and a simple mastectomy was performed. Two of the patients were postoperatively treated with tamoxifen; another patient was treated with adjuvant chemotherapy using taxotere and cyclophosphamide before tamoxifen. There was no recurrence in any of the three patients during an average follow-up period of 56.7 months (range 11.8–80.3). A sentinel lymph node biopsy is recommended for node staging in both male and female breast cancer patients as it is associated with a lower incidence of complications.

No MeSH data available.


Related in: MedlinePlus

A preoperative chest CT scan showing the incisional biopsy scar (arrow) of the right breast carcinoma
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4593990&req=5

Fig1: A preoperative chest CT scan showing the incisional biopsy scar (arrow) of the right breast carcinoma

Mentions: A 64-year-old man presented to his family doctor complaining of a tumor in his right breast that had been present for 2 years. A CT showed a round tumor of 10 mm in diameter under the nipple. There was no evidence of axillary lymph node swelling or metastatic disease (Fig. 1). Mammography (MMG) and ultrasonography (US) were not performed. An excisional biopsy was performed, which revealed an invasive ductal carcinoma with a close margin (<5 mm). He was introduced to our hospital for operation. The clinical diagnosis was cT1cN0M0, stage I. Because the pathological margin of the excisional biopsy was close (<5 mm), we explained to the merits and demerits of the different procedures (including partial mastectomy or total mastectomy), and an operation was selected. In our breast surgery department, MRI of the breast is usually performed for patients who intend to undergo partial mastectomy. We therefore performed total mastectomy and SLNB.Fig. 1


The clinical manifestations and treatment of male breast cancer: a report of three cases
A preoperative chest CT scan showing the incisional biopsy scar (arrow) of the right breast carcinoma
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4593990&req=5

Fig1: A preoperative chest CT scan showing the incisional biopsy scar (arrow) of the right breast carcinoma
Mentions: A 64-year-old man presented to his family doctor complaining of a tumor in his right breast that had been present for 2 years. A CT showed a round tumor of 10 mm in diameter under the nipple. There was no evidence of axillary lymph node swelling or metastatic disease (Fig. 1). Mammography (MMG) and ultrasonography (US) were not performed. An excisional biopsy was performed, which revealed an invasive ductal carcinoma with a close margin (<5 mm). He was introduced to our hospital for operation. The clinical diagnosis was cT1cN0M0, stage I. Because the pathological margin of the excisional biopsy was close (<5 mm), we explained to the merits and demerits of the different procedures (including partial mastectomy or total mastectomy), and an operation was selected. In our breast surgery department, MRI of the breast is usually performed for patients who intend to undergo partial mastectomy. We therefore performed total mastectomy and SLNB.Fig. 1

View Article: PubMed Central

ABSTRACT

Male breast cancer is an extremely rare malignancy. We treated three male breast cancer patients. All three patients showed clinical N0 and received sentinel lymph node biopsy. Because the sentinel lymph node was positive for metastasis in one patient, a total mastectomy with axillary lymph node dissection was performed. The other two patients were negative for sentinel lymph node metastasis, and a simple mastectomy was performed. Two of the patients were postoperatively treated with tamoxifen; another patient was treated with adjuvant chemotherapy using taxotere and cyclophosphamide before tamoxifen. There was no recurrence in any of the three patients during an average follow-up period of 56.7&nbsp;months (range 11.8&ndash;80.3). A sentinel lymph node biopsy is recommended for node staging in both male and female breast cancer patients as it is associated with a lower incidence of complications.

No MeSH data available.


Related in: MedlinePlus